Published in Pain and Central Nervous System Week, July 11th, 2005
Reminyl XL is a new once-daily treatment for the symptoms of mild to moderately severe Alzheimer disease.
In clinical trials, Reminyl XL demonstrated comparable efficacy, safety and tolerability to twice-daily Reminyl tablets with the added convenience of once-daily dosing. In particular, a clinical study of 965 patients showed there was no significant difference in cognitive benefits between patients treated with Reminyl XL and Reminyl according to the Alzheimer Disease...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week